Related Experiment Videos
RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity
1E. C. Slater Instituut, BioCentrum Amsterdam, University of Amsterdam, 1018 TV Amsterdam, The Netherlands.
Molecular and Cellular Biology
|December 22, 1998
Summary
RING1 protein interacts with multiple Polycomb-group (PcG) proteins, revealing its crucial role in gene regulation. Deregulation of RING1 drives oncogenic transformation by altering proto-oncogene expression.
Area of Science:
- Epigenetics and Gene Regulation
- Molecular Biology
- Cancer Biology
Background:
- Polycomb-group (PcG) proteins maintain gene silencing.
- RING1's role within PcG complexes is largely unknown.
- Previous work indicated RING1 interacts with PcG homologs.
Purpose of the Study:
- To characterize RING1 protein-protein interactions within PcG complexes.
- To investigate the functional consequences of RING1 overexpression on gene expression and cellular transformation.
Main Methods:
- Directed two-hybrid assays.
- In vitro protein-protein interaction analyses.
- Mammalian cell overexpression studies and gene expression analysis.
- Anchorage-independent growth assays and tumor induction in athymic mice.
Main Results:
- RING1 interacts with itself, HPC2, and BMI1.
- Distinct domains mediate RING1 self-association and BMI1 interaction.
- RING1 overexpression represses En-2 and enhances c-jun and c-fos expression.
- Overexpression leads to cellular transformation and tumor formation.
Conclusions:
- RING1 is a key component of the PcG complex with significant roles in gene regulation.
- RING1 deregulation contributes to oncogenesis through altered proto-oncogene expression.
- RING1's interactions highlight its importance in maintaining cellular homeostasis.